Rituximab in Pretreated Elderly or Unfit B-CLL Patients

NCT01576588 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

B-Cell Chronic Lymphocytic Leukemia

Interventions

DRUG: Rituximab
DRUG: Glucocorticoid

Sponsor

Prof. Dr. Med. Laimonas Griskevicius